BGI Genomics

BGI Genomics, established in 1999, is a prominent global provider of genomics and life science solutions. Originally part of the Beijing Genomics Institute, BGI has grown into one of the largest genomics organizations worldwide. The company has made significant contributions to major projects like the International Human Genome Project and the 1000 Genomes Project. With operations in over 60 countries, BGI emphasizes advancements in sequencing technologies, precision medicine, and agricultural applications. BGI offers a range of integrated solutions, including high-throughput DNA sequencing, bioinformatics, and diagnostic products. Their sequencing instruments, developed by MGI Tech, include ultra-high-throughput sequencers and clinical gene sequencers. BGI also provides diagnostic tests, such as the NIFTY test for prenatal screening and reagents for pathogen detection. Additionally, BGI engages in research services for drug development and agricultural engineering, and it supports education and talent training through BGI College. The company collaborates with various research institutions, medical facilities, and agricultural companies globally.